For example, tofacitinib, a JAK3-specific inhibitor, is used to treat ankylosing spondylitis (AS), rheumatoid arthritis (RA), psoriasis, psoriatic arthritis, ulcerative colitis, polyarticular juvenile idiopathic arthritis, etc. (41). This evidence concerns the gene JAK3 and psoriatic arthritis.